Swiss drugmaker Novartis said on Saturday it had received a binding offer from Germany’s Siemens Healthineers to acquire its molecular imaging business for Fluorine-18 positron emission tomography, or PET scans.
In a statement sent to Reuters, Novartis did not confirm the value of the deal but said Siemens Healthineers would remain a partner in the Novartis radioligand therapy business, adding that it expects the transaction to close in the fourth quarter.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States United States Latest News, United States United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
Siemens quarterly profit beats market view on electrification, softwareGerman industrial gear maker Siemens posted better-than-expected earnings growth during the April-to-June quarter, buoyed by customers who are upgrading...
Source: YahooFinanceCA - 🏆 47. / 63 Read more »
A German diaspora in North Carolina is booming thanks to a multibillion-dollar investment from Germany, but a potential Trump Presidency is causing anxietyThousands of Germans have flocked to North Carolina in recent years, aided by investments from Siemens and Daimler.
Source: YahooFinanceCA - 🏆 47. / 63 Read more »